Ping Ruan

679 total citations
25 papers, 557 citations indexed

About

Ping Ruan is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ping Ruan has authored 25 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 9 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Ping Ruan's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Ping Ruan is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (7 papers). Ping Ruan collaborates with scholars based in United States, China and Argentina. Ping Ruan's co-authors include Robert J. Gray, Hulin Wu, Yuanzhi Lao, Wei Xu, Zhenyan Liu, Naihan Xu, Hong‐Xi Xu, Gang Wan, Yaou Zhang and Xiaoyu Wang and has published in prestigious journals such as Journal of Virology, Journal of Allergy and Clinical Immunology and The Journal of Infectious Diseases.

In The Last Decade

Ping Ruan

23 papers receiving 548 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Ruan United States 14 177 161 145 121 57 25 557
Yiannis Bassiakos Greece 11 148 0.8× 177 1.1× 67 0.5× 130 1.1× 40 0.7× 19 507
Jos Weusten Netherlands 15 206 1.2× 100 0.6× 170 1.2× 42 0.3× 140 2.5× 31 705
Stephen E. Maxwell United States 15 125 0.7× 167 1.0× 161 1.1× 23 0.2× 9 0.2× 20 722
Ferdous Gheyas United States 13 97 0.5× 48 0.3× 312 2.2× 175 1.4× 21 0.4× 26 875
Tsunefusa Hayashida Japan 14 202 1.1× 423 2.6× 81 0.6× 277 2.3× 77 1.4× 31 655
Zhengtong Lv China 11 70 0.4× 208 1.3× 266 1.8× 113 0.9× 16 0.3× 35 722
Jingyang Zhang China 13 174 1.0× 178 1.1× 136 0.9× 58 0.5× 39 0.7× 53 661
Yan Zhuang China 12 113 0.6× 85 0.5× 79 0.5× 76 0.6× 49 0.9× 83 489
Enrica Alteri Switzerland 13 58 0.3× 94 0.6× 97 0.7× 109 0.9× 17 0.3× 21 602
Grant Langdon United Kingdom 12 167 0.9× 293 1.8× 127 0.9× 22 0.2× 7 0.1× 28 736

Countries citing papers authored by Ping Ruan

Since Specialization
Citations

This map shows the geographic impact of Ping Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Ruan more than expected).

Fields of papers citing papers by Ping Ruan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Ruan. The network helps show where Ping Ruan may publish in the future.

Co-authorship network of co-authors of Ping Ruan

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Ruan. A scholar is included among the top collaborators of Ping Ruan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Ruan. Ping Ruan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yang, Chun, Ping Ruan, Chao Ou, et al.. (2015). Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (Tupaia belangeri chinensis). Virology Journal. 12(1). 26–26. 45 indexed citations
3.
Lao, Yuanzhi, Gang Wan, Zhenyan Liu, et al.. (2014). The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation. Autophagy. 10(5). 736–749. 119 indexed citations
4.
Ruan, Ping, Chun Yang, Jianjia Su, et al.. (2013). Histopathological changes in the liver of tree shrew (Tupaia belangeri chinensis) persistently infected with hepatitis B virus. Virology Journal. 10(1). 333–333. 27 indexed citations
6.
Singh, Kumud K., et al.. (2008). An age-dependent association of mannose-binding lectin-2 genetic variants on HIV-1–related disease in children. Journal of Allergy and Clinical Immunology. 122(1). 173–180.e2. 24 indexed citations
7.
Ruan, Ping & Robert J. Gray. (2008). Analyses of cumulative incidence functions via non‐parametric multiple imputation. Statistics in Medicine. 27(27). 5709–5724. 59 indexed citations
8.
Salazar, Juan C., Pedro Cahn, Ram Yogev, et al.. (2008). Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents. AIDS. 22(14). 1789–1798. 29 indexed citations
9.
Palumbo, Paul, Hulin Wu, Ellen G. Chadwick, et al.. (2007). Virologic Response to Potent Antiretroviral Therapy and Modeling of HIV Dynamics in Early Pediatric Infection. The Journal of Infectious Diseases. 196(1). 23–29. 20 indexed citations
10.
Ruan, Ping & Robert J. Gray. (2007). Sensitivity analysis of progression‐free survival with dependent withdrawal. Statistics in Medicine. 27(8). 1180–1198. 9 indexed citations
11.
Ruan, Ping & Robert J. Gray. (2006). A Method for Analyzing Disease-Specific Mortality with Missing Cause of Death Information. Lifetime Data Analysis. 12(1). 35–51. 3 indexed citations
12.
Xie, Siming, et al.. (2006). [Expression of tumor suppressor gene PTEN, PIP3 and cyclin D1 in oral squamous cell carcinoma and their correlations].. PubMed. 41(7). 407–10. 2 indexed citations
13.
Xie, Siming, et al.. (2005). [Expressions of PTEN and FHIT in oral squamous cell carcinoma and their relations with cyclin D1].. PubMed. 25(1). 79–82. 1 indexed citations
14.
Xie, Siming, et al.. (2005). [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].. PubMed. 25(5). 584–6.
15.
Xie, Siming, et al.. (2005). [Expressions of FHIT and cyclin D1/CDK4 in oral cancer and oral precancerous lesions].. PubMed. 25(7). 812–4. 3 indexed citations
16.
17.
Frank, Ian, Ronald J. Bosch, Susan A. Fiscus, et al.. (2004). Activity, Safety, and Immunological Effects of Hydroxyurea Added to Didanosine in Antiretroviral-Naive and Experienced HIV Type 1-Infected Subjects: A Randomized, Placebo-Controlled Trial, ACTG 307. AIDS Research and Human Retroviruses. 20(9). 916–926. 21 indexed citations
18.
Wu, Hulin, John W. Mellors, Ping Ruan, et al.. (2003). Viral Dynamics and Their Relations to Baseline Factors and Longer Term Virologic Responses in Treatment-Naive HIV-1–Infected Patients Receiving Abacavir in Combination with HIV-1 Protease Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(5). 557–563. 21 indexed citations
19.
Hamzeh, Fayez M., Constance A. Benson, John G. Gerber, et al.. (2003). Steady‐state pharmacokinetic interaction of modified‐dose indinavir and rifabutin. Clinical Pharmacology & Therapeutics. 73(3). 159–169. 31 indexed citations
20.
Wu, Hulin, Ping Ruan, A. Adam Ding, John L. Sullivan, & Katherine Luzuriaga. (1999). Inappropriate Model-Fitting Methods May Lead to Significant Underestimates of Viral Decay Rates in HIV Dynamic Studies. JAIDS Journal of Acquired Immune Deficiency Syndromes. 21(5). 426–426. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026